15 / 25
Page 39
Notes:
allied
academies
Journal of Materials Science and Nanotechnology | Volume: 3
March 20-21, 2019 | London, UK
Materials Science and Materials Chemistry
2
nd
International Conference on
N
anotechnology is revolutionizing the field of medicine.
While several decades ago, there were not many
nanotechnology-derivedmedical devices approval by regulatory
agencies (such as the FDA), today there are over a dozen today.
This keynote talk will cover reasons why one should consider
using nanotechnology for medical devices to improve tissue
growth, decrease infection and reduce inflammation- all criteria
necessary for the next generation of improved medical devices.
It will cover several examples of FDA approved materials. It will
also look towards the future and describe how nanotechnology
is being used in the generation of implantable nanosensors that
can assess tissue responses to implants, send such information
to a cell phone, and have an implant that responds on-demand
to detrimental biological events.
Speaker Biography
Thomas J Webster’s degrees are in chemical engineering from the University of Pittsburgh
(B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S.,
1997;Ph.D.,2000).Websterhasgraduated/supervisedover189studentsandhaspublished
over 583 peer-reviewed literature articles forming 11 companies with 5 FDA approved
implants. Webster currently directs or co-directs 5 centers in the area of biomaterials and
is a fellow of 6 academic societies. He has appeared on numerous news channels and the
recent special “Year Million” TV series on National Geographic talking about the future of
medicine and science.
e:
th.webster@neu.eduThomas J Webster
Northeastern University, USA
Two decades of commercializing nanomedicine: Frommedical devices to drug carriers
to implantable sensors